-
Editor’s pick: Gate Bioscience Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-20
Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Gate Bioscience wants to tailor gates that stop problematic proteins at the source.
-
Clinical validation of a wearable ultrasound sensor of blood pressure Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-20 Sai Zhou, Geonho Park, Katherine Longardner, Muyang Lin, Baiyan Qi, Xinyi Yang, Xiaoxiang Gao, Hao Huang, Xiangjun Chen, Yizhou Bian, Hongjie Hu, Ray S. Wu, Wentong Yue, Mohan Li, Chengchangfeng Lu, Ruotao Wang, Siyu Qin, Esra Tasali, Theodore Karrison, Isac Thomas, Benjamin Smarr, Erik B. Kistler, Belal Al Khiami, Irene Litvan, Sheng Xu
-
Endocytic tagging for degradation Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-19 Filipe V. Almeida
-
Streamlined Clarification and Capture Process for Monoclonal Antibodies Using Fluidized Bed Centrifugation and Multi‐Column Chromatography With Membrane Adsorbers Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-19 Fabian Schmitz, Martin Saballus, Thomas Kruse, Mirjana Minceva, Markus Kampmann
Harmonizing unit operations in the downstream process of monoclonal antibodies (mAbs) has a high potential to overcome throughput limitations and reduce manufacturing costs. This study proposes a streamlined clarification and capture (S‐CC) process concept for the continuous processing of cell broth harvested from a connected bioreactor. The process was realized with a fluidized bed centrifuge connected
-
Regeneration of Spent Culture Media for Sustainable and Continuous mAb Production via Ion Concentration Polarization Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-19 Eric Wynne, Junghyo Yoon, Dohyun Park, Mingyang Cui, Caitlin Morris, Jaeweon Lee, Zhao Wang, Seongkyu Yoon, Jongyoon Han
In modern bioprocessing, cell culture media is one of the most significant cost drivers, yet the nutrients and other critical factors in the media are often not fully utilized. With the renewed emphasis on reducing the cost of bioprocessing, there is much interest in reducing the overall use of cell culture media. In this work, we introduce a mesoscale microfluidic separation device based on the ion
-
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-18 Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy, Jaime Fuentealba, Lisseth Silva, Laetitia Perrin, Sandrine Heurtebise-Chrétien, Valentine Pottez-Jouatte, Aurelie Darbois, Nina Burgdorf, Anne-Laure Privat, Albane Simon, Marguerite Laprie-Sentenac, Michael Saitakis, Bryce Wick, Beau R. Webber, Branden S. Moriarity, Olivier Lantz, Sebastian Amigorena, Laurie Menger
-
-
-
Stress impacts immunity via the gut Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-15 Jennifer Haskell
-
Dyeing mice transparent Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-15 Alessandra Griffo
A water-soluble dye that absorbs blue light strongly makes it easier to turn mice transparent.
-
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffii Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-15 Yuchen Yang, Neil C. Dalvie, Joseph R. Brady, Christopher A. Naranjo, Timothy Lorgeree, Sergio A. Rodriguez‐Aponte, Ryan S. Johnston, Mary K. Tracey, Carmen M. Elenberger, Eric Lee, Mark Tié, Kerry R. Love, J. Christopher Love
Monoclonal antibodies (mAbs) are a major class of biopharmaceuticals manufactured by well‐established processes using Chinese Hamster Ovary (CHO) cells. Next‐generation biomanufacturing using alternative hosts like Komagataella phaffii could improve the accessibility of these medicines, address broad societal goals for sustainability, and offer financial advantages for accelerated development of new
-
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-14 Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel, Eun Jung Choi, Andrea Alvarado, Ebony Cottman-Thomas, Damian Maseda, Patricia Y. Tsao, Christoph T. Ellebrecht, Sami L. Khella, David P. Richman, Kevin C. O’Connor, Uri Herzberg, Gwendolyn K. Binder, Michael C. Milone, Samik Basu, Aimee S. Payne
Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-022-01637-z, published online 19 January 2023.
-
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-13 Aditya Raguram, Meirui An, Paul Z. Chen, David R. Liu
-
Biotech news from around the world Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
Wageningen-based agbiotech KeyGene, in collaboration with Chiquita and Wageningen University, develops a banana plant resistant to both Fusarium tropical race 4 (TR4), a fungus capable of devastating entire plantations, and black sigatoka, a widespread leaf disease. The new variety, named Yelloway One, was produced by combining traditional crossbreeding techniques and modern DNA analysis technology
-
A bacterial neoantigen cancer vaccine Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Iris Marchal
Neoantigen cancer vaccines hold great promise for cancer treatment but are often limited by the immunosuppressive tumor environment. Now, as described in Nature, Redenti et al. have overcome this issue by harnessing the natural capacity of bacteria to colonize tumors and trigger immune responses. They have developed a microbial system that produces and delivers distinct sets of neoantigens to elicit
-
First proof-of-mechanism for RNA editing in humans Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
The first clinical results for an RNA-editing oligonucleotide designed to correct a disease-causing single-base mutation in mRNA have been released. The company, Wave Life Sciences, says the agent WVE-006 restored more than 60% of wild-type functional protein in two individuals with the genetic disorder alpha-1 antitrypsin (ATT; encoded by SERPINA1) deficiency. ATT deficiency affects the liver owing
-
Shot in the arm for biotech fuels Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
The US Department of Energy (DOE) in October conditionally committed nearly $3 billion to two companies to scale up the production of sustainable jet fuel made from crops, vegetable oils and animal fats. Gevo in Englewood, Colorado, could receive a loan guarantee of nearly $1.5 billion to build a new jet fuel refinery in Lake Preston, South Dakota. And Montana Renewables could receive about the same
-
Cancer cases in bluebird’s gene therapy trials Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
Over 10% of patients with a fatal neurodegenerative disease who received bluebird bio’s FDA-approved gene therapy Skysona (elivaldogene autotemcel) have developed hematological cancers, further highlighting the well-known risks of using lentiviral vectors. The patients were treated with Skysona to slow the progression of cerebral adrenoleukodystrophy (CALD), an X-linked rare inherited neurodegenerative
-
From Bench to Podcast: Ali Shaib Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
In this episode, Associate Editor Cláudia Vilhena sits down with Ali Shaib, the lead author of an exciting new study showcasing expansion microscopy and the visualization of individual protein shapes using standard laboratory microscopes. Tune in as Ali and Cláudia explore the “accidental” origins of the study, the importance of mentorship and collaboration, and the democratization of super-resolution
-
Wasp gut microbes yield beer with extra tang Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
Beer lovers can now enjoy their wildest drink yet thanks to a yeast carried by wasps. AB Biotek from Peterborough in the UK has launched Pinnacle Crisp Sour — a brewer’s ingredient made from Lachancea thermotolerans, a yeast found in the bellies of wasps. Traditional beer uses just four ingredients: grain, hops, yeast and water. Hops add the distinctive bitter flavor, and yeast converts sugar from
-
Virus-like elements Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
Recent patents relating to retroviruses, transposons and other virus-like elements for use in gene transfer and gene therapy.
-
LucaProt reveals the diverse global RNA virome Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Iris Marchal
RNA viruses are omnipresent and can infect a wide range of hosts. Recent efforts to sequence ecological samples have identified tens of thousands of new species, yet uncovering the complete spectrum of RNA virus diversity remains challenging. In a new paper published in Cell, Hou et al. describe a deep learning algorithm, called LucaProt, to advance RNA virus discovery at global scale. LucaProt is
-
Glucose-responsive insulin for diabetes Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Iris Marchal
Using insulin to control diabetes can lead to dangerously low blood glucose levels (hypoglycemia). For many years, researchers have worked to engineer an insulin that avoids this risk by adjusting its activity in response to glucose, but so far without success. Writing in Nature, Hoeg-Jensen et al. describe an insulin with a glucose-sensitive switch that reversibly responds to ambient glucose levels
-
People Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12
Recent moves of note in and around the biotech and pharma industries.
-
Who made the mRNA vaccine? Measuring division of labor in therapeutic innovation Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Martin Ho, Henry C. W. Price, Tim S. Evans, Eoin O’Sullivan
-
Behind the graduate mental health crisis in science Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Carly A. Busch, Nicholas J. Wiesenthal, Logan E. Gin, Katelyn M. Cooper
-
Perfusion Process Intensification for Lentivirus Production Using a Novel Scale‐Down Model Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-13 Maximilian Klimpel, Beatrice Pflüger‐Müller, Marta Arrizabalaga Cascallana, Sarah Schwingal, Nikki Indresh Lal, Thomas Noll, Vicky Pirzas, Holger Laux
-
Multimodal scanning of genetic variants with base and prime editing Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Olivier Belli, Kyriaki Karava, Rick Farouni, Randall J. Platt
-
Beyond the blood: expanding CAR T cell therapy to solid tumors Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Ugur Uslu, Carl H. June
-
Saturation profiling of drug-resistant genetic variants using prime editing Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-12 Younggwang Kim, Hyeong-Cheol Oh, Seungho Lee, Hyongbum Henry Kim
-
Amyloid is everywhere, but new treatments could stop the toxic build up Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-11
Amyloid deposits are present in the brains of cognitively impaired individuals, but also accumulate throughout the body. Some biotechs aim to keep these misfolded proteins in check to treat a range of diseases, including heart failure, ALS and Alzheimer’s disease.
-
Endocisternal interfaces for minimally invasive neural stimulation and recording of the brain and spinal cord Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-11 Joshua C. Chen, Abdeali Dhuliyawalla, Robert Garcia, Ariadna Robledo, Joshua E. Woods, Fatima Alrashdan, Sean O’Leary, Adam Husain, Anthony Price, Scott Crosby, Michelle M. Felicella, Ajay K. Wakhloo, Patrick Karas, Nicole Provenza, Wayne Goodman, Sameer A. Sheth, Sunil A. Sheth, Jacob T. Robinson, Peter Kan
-
Fusarium as a promising fungal genus with potential application in bioremediation for pollutants mitigation: A review Biotechnol. Adv. (IF 12.1) Pub Date : 2024-11-12 Carmen Sánchez
Fusarium is genetically diverse and widely distributed geographically. It is one of the genera with more endophytes (which cause no damage to the host plants). This review highlights the capability of Fusarium species to degrade environmental pollutants and describes the biodegradation pathways of some of the emerging environmental contaminants. Some Fusarium species use metabolic strategies enabling
-
The faucet knob effect of DptE crotonylation on the initial flow of daptomycin biosynthesis. Metab. Eng. (IF 6.8) Pub Date : 2024-11-12 Wen-Li Gao,Lie Ma,Meng-Han Li,Wei-Feng Xu,Chen-Fan Sun,Qing-Wei Zhao,Xin-Ai Chen,Zhong-Yuan Lyu,Yong-Quan Li
We propose here that acylation modification of actinomycete proteins is a restrictive system that limits the excessive synthesis of secondary metabolites, its mechanism has not been clearly elucidated before. We used crotonylation as an example to investigate the acylation effect in the daptomycin biosynthesis by Streptomyces roseosporus. Our experiments revealed abundant crotonylation of numerous
-
Versatile Xylose and Arabinose Genetic Switches development for Yeasts. Metab. Eng. (IF 6.8) Pub Date : 2024-11-11 Shuhui Guo,Juhua Du,Donghan Li,Jinghui Xiong,Ye Chen
Inducible transcription systems are essential tools in genetic engineering, where tight control, strong inducibility and fast response with cost-effective inducers are highly desired. However, existing systems in yeasts are rarely used in large-scale fermentations due to either cost-prohibitive inducers or incompatible performance. Here, we developed powerful xylose and arabinose induction systems
-
Biotechnology and Bioengineering: Volume 121, Number 12, December 2024 Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-11
Click on the article title to read more.
-
Correction to “A High‐Throughput Expression and Screening Platform for Applications‐Driven PETase Engineering” Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-11
Zurier, H. S., & Goddard, J. M. (2023). A High-Throughput Expression and Screening Platform for Applications-Driven PETase Engineering. Biotechnology and Bioengineering 120, 1000–1014. https://doi.org/10.1002/bit.28319 In the originally published article, one of the references was cited incorrectly. The incorrect reference is: Ebersbach, H., Geisse, S., Vincent, K. J., Zurini, M., McNeely, P. M., Naranjo
-
A stealthy neural recorder for the study of behaviour in primates Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-08 Saehyuck Oh, Janghwan Jekal, Jinyoung Won, Kyung Seob Lim, Chang-Yeop Jeon, Junghyung Park, Hyeon-Gu Yeo, Yu Gyeong Kim, Young Hee Lee, Leslie Jaesun Ha, Han Hee Jung, Junwoo Yea, Hyeokjun Lee, Jeongdae Ha, Jinmo Kim, Doyoung Lee, Soojeong Song, Jieun Son, Tae Sang Yu, Jungmin Lee, Sanghoon Lee, Jaehong Lee, Bong Hoon Kim, Ji-Woong Choi, Jong-Cheol Rah, Young Min Song, Jae-Woong Jeong, Hyung Jin Choi
-
Mathematical Modeling and Simulation of 1,3‐Propanediol Production by Klebsiella pneumoniae BLh‐1 in a Batch Bioreactor Using Bayesian Statistics Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-08 Nathalia Lobato Moraes, Mailson Batista de Vilhena, Daniele Misturini Rossi, Bruno Marques Viegas
-
Implemention of Innovative Process Analytical Technologies to Characterize Critical Quality Attributes of Co‐Formulated Monoclonal Antibody Products Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-08 Apurva Godbole, Lyufei Chen, Jay Desai, Smita Raghava, Richard Ruzanski, Bhumit Patel, Emmanuel Appiah‐Amponsah, Hanzhou Feng
-
Metabolic engineering of Corynebacterium glutamicum: Unlocking its potential as a key cell factory platform for organic acid production Biotechnol. Adv. (IF 12.1) Pub Date : 2024-11-07 Ming-Hou Li, Han Li, Xue Zhang, Yu-Chen Liang, Cheng Li, Meng-Lin Sun, Kai Li, Chen-Guang Liu, Anthony J. Sinskey
Corynebacterium glutamicum, a well-studied industrial model microorganism, has garnered widespread attention due to its ability for producing amino acids with a long history. In recent years, research efforts have been increasingly focused on exploring its potential for producing various organic acids beyond amino acids. Organic acids, which are characterized by their acidic functional groups, have
-
Microbial electrosynthesis technology for CO2 mitigation, biomethane production, and ex-situ biogas upgrading Biotechnol. Adv. (IF 12.1) Pub Date : 2024-11-07 Tae Hyun Chung, Simran Kaur Dhillon, Chungheon Shin, Deepak Pant, Bipro Ranjan Dhar
Currently, global annual CO2 emissions from fossil fuel consumption are extremely high, surpassing tens of billions of tons, yet our capacity to capture and utilize CO2 remains below a small fraction of the amount generated. Microbial electrosynthesis (MES) systems, an integration of microbial metabolism with electrochemistry, have emerged as a highly efficient and promising bio-based carbon-capture-and-utilization
-
Metabolic Engineering of Nonmodel Yeast Issatchenkia orientalis SD108 for 5‐Aminolevulinic Acid Production Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-07 Shih‐I Tan, I‐Son Ng, Huimin Zhao
Biological production of 5‐aminolevulinic acid (5‐ALA) has received growing attention over the years. However, there is the tradeoff between 5‐ALA biosynthesis and cell growth because the fermentation broth will become acidic due to the production of 5‐ALA. To address this limitation, we engineered an acid‐tolerant yeast, Issatchenkia orientalis SD108, for 5‐ALA production. We first discovered that
-
Italy tests first gene-edited vines for winemaking Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-06
Europe’s first field trial of gene-edited vines began in northern Italy on 30 September 2024. Developed by EdiVite, a spinoff from the University of Verona, these Chardonnay vines have undergone gene inactivation to enable them to better defend themselves against downy mildew, a major fungal disease. The trial is being conducted on university land, with plans to expand to another site in the Veneto
-
CRISPR Nobelists surrender their own European patents Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-04
A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPR–Cas9 technology.
-
Ancient and versatile CRISPR–Cas nuclease created with ancestral sequence reconstruction Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-05
-
Biotechnological applications of purine and pyrimidine deaminases Biotechnol. Adv. (IF 12.1) Pub Date : 2024-11-05 Jon Del Arco, Javier Acosta, Jesús Fernández-Lucas
Deaminases, ubiquitous enzymes found in all living organisms from bacteria to humans, serve diverse and crucial functions. Notably, purine and pyrimidine deaminases, while biologically essential for regulating nucleotide pools, exhibit exceptional versatility in biotechnology. This review systematically consolidates current knowledge on deaminases, showcasing their potential uses and relevance in the
-
Oxygen Consumption in Filamentous Pellets of Aspergillus niger: Microelectrode Measurements and Modeling Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-05 Charlotte Deffur, Anna Dinius, Julian Pagel, Henri Müller, Stefan Schmideder, Heiko Briesen, Rainer Krull
-
What will it take to get miRNA therapies to market? Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-04
The Nobel Prize in medicine was awarded for the discovery of miRNA, but miRNA therapeutics have a long way to go before they outcompete other therapies.
-
AIntibody: an experimentally validated in silico antibody discovery design challenge Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-04 M. Frank Erasmus, Laura Spector, Fortunato Ferrara, Roberto DiNiro, Thomas J. Pohl, Katheryn Perea-Schmittle, Wei Wang, Peter M. Tessier, Crystal Richardson, Laure Turner, Sumit Kumar, Daniel Bedinger, Pietro Sormanni, Monica L. Fernández-Quintero, Andrew B. Ward, Johannes R. Loeffler, Olivia M. Swanson, Charlotte M. Deane, Matthew I. J. Raybould, Andreas Evers, Carolin Sellmann, Sharrol Bachas, Jeff
-
Binary vector copy number engineering improves Agrobacterium-mediated transformation Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-04 Matthew J. Szarzanowicz, Lucas M. Waldburger, Michael Busche, Gina M. Geiselman, Liam D. Kirkpatrick, Alexander J. Kehl, Claudine Tahmin, Rita C. Kuo, Joshua McCauley, Hamreet Pannu, Ruoming Cui, Shuying Liu, Nathan J. Hillson, Jacob O. Brunkard, Jay D. Keasling, John M. Gladden, Mitchell G. Thompson, Patrick M. Shih
-
Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-04 Thomas D. Avery, Jiahe Li, Dion J. L. Turner, Mohd S. U. Rasheed, Fisher R. Cherry, Damian L. Stachura, Fátima Rivera-Escalera, David M. Ruiz, Michael J. Lacagnina, Caitlyn M. Gaffney, Clarissa Aguilar, Jingxian Yu, Yang Wang, Huan Xie, Dong Liang, Andrew J. Shepherd, Andrew D. Abell, Peter M. Grace
-
Large DNA deletions occur during DNA repair at 20-fold lower frequency for base editors and prime editors than for Cas9 nucleases Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-11-04 Gue-Ho Hwang, Seok-Hoon Lee, Minsik Oh, Segi Kim, Omer Habib, Hyeon-Ki Jang, Heon Seok Kim, Youngkuk Kim, Chan Hyuk Kim, Sun Kim, Sangsu Bae
-
Heterologous biosynthesis of betanin triggers metabolic reprogramming in tobacco Metab. Eng. (IF 6.8) Pub Date : 2024-11-04 Xun Jiang, Zhuoxiang Zhang, Xiuming Wu, Changmei Li, Xuan Sun, Fengyan Wu, Aiguo Yang, Changqing Yang
Engineering of a specialized metabolic pathway in plants is a promising approach to produce high-value bioactive compounds to address the challenges of climate change and population growth. Understanding the interaction between the heterologous pathway and the native metabolic network of the host plant is crucial for optimizing the engineered system and maximizing the yield of the target compound.
-
Urea‐Loaded PLGA Microspheres as Chemotaxis Stimulants for Helicobacter pylori Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-04 Prasanth Shanmughan, Pravin Subrahmaniyan, Dhruv Bhatnagar, Srinithi Ranganathan, Pushkar P. Lele
-
Development of compact transcriptional effectors using high-throughput measurements in diverse contexts Nat. Biotechnol. (IF 33.1) Pub Date : 2024-11-01 Josh Tycko, Mike V. Van, Aradhana, Nicole DelRosso, Hanrong Ye, David Yao, Raeline Valbuena, Alun Vaughan-Jackson, Xiaoshu Xu, Connor Ludwig, Kaitlyn Spees, Katherine Liu, Mingxin Gu, Venya Khare, Adi Xiyal Mukund, Peter H. Suzuki, Sophia Arana, Catherine Zhang, Peter P. Du, Thea S. Ornstein, Gaelen T. Hess, Roarke A. Kamber, Lei S. Qi, Ahmad S. Khalil, Lacramioara Bintu, Michael C. Bassik
-
A resurrected ancestor of Cas12a expands target access and substrate recognition for nucleic acid editing and detection Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-31 Ylenia Jabalera, Igor Tascón, Sara Samperio, Jorge P. López-Alonso, Monika Gonzalez-Lopez, Ana M. Aransay, Guillermo Abascal-Palacios, Chase L. Beisel, Iban Ubarretxena-Belandia, Raul Perez-Jimenez
-
Engineering peroxisomal surface display for enhanced biosynthesis in the emerging yeast Kluyveromyces marxianus Metab. Eng. (IF 6.8) Pub Date : 2024-11-01 Shane Bassett, Jonathan C. Suganda, Nancy A. Da Silva
The non-conventional yeast Kluyveromyces marxianus is a promising microbial host for industrial biomanufacturing. With the recent development of Cas9-based genome editing systems and other novel synthetic biology tools for K. marxianus, engineering of this yeast has become far more accessible. Enzyme colocalization is a proven approach to increase pathway flux and the synthesis of non-native products
-
Generation of a Vibrio-based platform for efficient conversion of raffinose through Adaptive Laboratory Evolution on a solid medium Metab. Eng. (IF 6.8) Pub Date : 2024-11-01 Sunghwa Woo, Yong Hee Han, Hye Kyung Lee, Dongyeop Baek, Myung Hyun Noh, Sukjae Han, Hyun Gyu Lim, Gyoo Yeol Jung, Sang Woo Seo
Raffinose, a trisaccharide abundantly found in soybeans, is a potential alternative carbon source for biorefineries. Nevertheless, residual intermediate di- or monosaccharides and low catabolic efficiency limit raffinose use through conventional microbial hosts. This study presents a Vibrio-based platform to convert raffinose efficiently. Vibrio sp. dhg was selected as the starting strain for the Adaptive
-
Design an Energy‐Conserving Pathway for Efficient Biosynthesis of 1,5‐Pentanediol and 5‐Amino‐1‐Pentanol Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-11-01 Lin Ma, Chong Xie, Yu Zhang, Wenna Li, Ning An, Xiaolin Shen, Jia Wang, Xinxiao Sun, Qipeng Yuan